Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Chemical Reagents >  Organic reagents >  4-Morpholinopiperidine

4-Morpholinopiperidine

Basic information Safety Supplier Related

4-Morpholinopiperidine Basic information

Product Name:
4-Morpholinopiperidine
Synonyms:
  • TIMTEC-BB SBB010091
  • 4-(PIPERIDIN-4-YL)-MORPHOLINE
  • AKOS BB-9182
  • CHEMBRDG-BB 4004473
  • 4-Morpholino-piperidin
  • 4-(PIPERIDIN-4-YL)-MORPHOLINE >98%
  • 4-MORPHOLINO-PIPERDINEDIHYDROCHLORIDE
  • 4-piperidin-4-ylmorpholine(SALTDATA: 2HCl)
CAS:
53617-35-9
MF:
C9H18N2O
MW:
170.25
EINECS:
627-580-3
Product Categories:
  • Building Blocks
  • Heterocyclic Building Blocks
  • Piperidines
Mol File:
53617-35-9.mol
More
Less

4-Morpholinopiperidine Chemical Properties

Melting point:
40-43 °C(lit.)
Boiling point:
100-115 °C0.15-0.20 mm Hg(lit.)
Density 
1.033±0.06 g/cm3(Predicted)
vapor pressure 
0.63-4.58Pa at 25-45℃
Flash point:
>230 °F
storage temp. 
Keep in dark place,Sealed in dry,Room Temperature
form 
Solid
pka
10.21±0.10(Predicted)
Appearance
Colorless to off-white Solid
InChI
InChI=1S/C9H18N2O/c1-3-10-4-2-9(1)11-5-7-12-8-6-11/h9-10H,1-8H2
InChIKey
YYBXNWIRMJXEQJ-UHFFFAOYSA-N
SMILES
N1(C2CCNCC2)CCOCC1
LogP
0.3 at 25℃ and pH11
Dissociation constant
5.44-10.1 at 20℃
More
Less

Safety Information

Hazard Codes 
Xi
Risk Statements 
36/37/38-20/21/22
Safety Statements 
26-36-36/37/39
WGK Germany 
3
HazardClass 
IRRITANT
HS Code 
29333990

MSDS

More
Less

4-Morpholinopiperidine Usage And Synthesis

Uses

Reactant for synthesis of:

  • Selective adenosine A2A receptor antagonists
  • Antidepressents
  • Small molecules that restore E-cadherin expression and reduce invasion in colorectal carcinoma cells
  • Orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation
  • Quinoline derivatives with antimicrobial activity
  • Antimalarials

Synthesis

415967-79-2

53617-35-9

General procedure for the synthesis of 4-(4-piperidinyl)morpholine from N-benzyl-4-(4-morpholinyl)piperidine: 41.59 g (0.16 mol) of N-benzyl-4-(4-morpholinyl)piperidine was dissolved in 400 mL of methanol, and 5.2 g of 10% palladium/carbon catalyst was added. The hydrogenation reaction was carried out at room temperature for 18 hours at 50 psi hydrogen pressure. Upon completion of the reaction, the catalyst was removed by filtration and the filtrate was concentrated. A colorless oily substance was obtained, which was left to crystallize. The yield was 25.29 g with 93% yield.

References

[1] Patent: US2008/45705, 2008, A1. Location in patent: Page/Page column 10-11
[2] Patent: US2003/69297, 2003, A1
[3] Patent: US2003/125370, 2003, A1

4-MorpholinopiperidineSupplier

Shanghai Yuanding Chem. Sci. & Tech. Co., Ltd. Gold
Tel
21-57721279
Email
sales@shydchem.com.cn
Shanghai Famo Bio-chemical Technology Company Ltd. Gold
Tel
021-02136680027 15800370750
Email
1706640024@qq.com
Chengdu aibike Pharmaceutical Technology Co., Ltd Gold
Tel
028-68517313 13708075524
Email
zhaozhong@emtco.cn
Rushpharm Co.,Ltd. Gold
Tel
025-66042949 15161141411
Email
2244332520@qq.com
Shanghai Hobor Chemical Co., Ltd Gold
Tel
021-57790084; 13918007836
Email
sales@hoborchem.com